Skip to main content
NewslettersWatchlist

Resverlogix Corp(RVX-T)
TSX

Today's Change
Real-Time Last Update

Stocks in play: Resverlogix Corp.

Baystreet.ca - Baystreet - Wed Oct 4, 2023

Today announced the publication of a peer-reviewed article, entitled "Apabetalone, a Clinical-stage, Selective BET Inhibitor, Opposes DUX4 Target Gene Expression in Primary Human FSHD Muscle Cells" in the journal Biomedicines. Resverlogix Corp. shares T.RVX are trading unchanged at $0.07.

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

report on business
Proxy advisers recommend investors vote ‘no’ on Shopify executive pay
Shopify offices in Toronto on May 13, 2024. May 13, 2024. (Sammy Kogan/The Globe and Mail)
market news
The close: Wall Street boasts fresh records as inflation data fuels rate-cut bets
Traders work on the floor of the New York Stock Exchange (NYSE) on May 3.
globe investor
Chevron tops Tesla as most-shorted stock in April, says Hazeltree
The Chevron Pascagoula Refinery is pictured in Pascagoula, Mississippi on Sept. 4, 2018.
market news
The close: Nasdaq at record high after Fed chair’s comments but TSX dips for third day
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 8.
market news
The close: S&P 500, TSX slip as investors await inflation data; meme rally reignites
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 8.
report on business
Shopify executive earned US$76-million in 2023, far outpacing CEO’s compensation
Kaz Nejatian, COO of Shopify, speaks at the Collision conference in Toronto, Wednesday, June 28, 2023. THE CANADIAN PRESS/Chris Young
market news
The close: S&P 500 higher but TSX slips as traders await key U.S. inflation data
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 8, 2024. REUTERS/Brendan McDermid/File Photo
inside the market
How pro money managers are balancing exposure to Canadian and U.S. stocks
Rob Carrick

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).